Fibromyositis after intramuscular pentazocine abuse [2]

Journal of Postgraduate Medicine

Volumn 48, Issue 3, 2002, Pages 239-

  Silva, M C ^a   Singh, P ^a   Murthy, P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; CREATINE KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTAZOCINE; PROMETHAZINE;

ABDOMINAL PAIN; ADULT; ANTISEPSIS; CASE REPORT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG ABUSE; DRUG TOLERANCE; HUMAN; LETTER; MALE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; POLYMYOSITIS; QUADRICEPS FEMORIS MUSCLE; WITHDRAWAL SYNDROME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MYOSITIS; PENTAZOCINE; RISK ASSESSMENT; SUBSTANCE-RELATED DISORDERS;

EID: 0036662969     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Ray R. Current extent and pattern of drug abuse. In: Ray R Editor. South Asia Drug Demand Reduction Report. New Delhi: United Nations International Drug Control Programme Regional office for South Asia; 1998. p. 6-31.
2. Das CP, Thussu A, Prabhakar S, Banerjee AK. Pentazocine induced fibromyositis and contracture. Postgrad Med J 1999;75:361-2.
3. Oh SJ, Rollins JL, Lewis I. Pentazocine induced fibrous myopathy. JAMA 1975;231:271-3.